The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Some of the biggest gainers among Manufacturing stocks include:
Amicus Therapeutics (FOLD): FOLD stock is up 10.15% today. Aquinox Pharmaceutic (AQXP): AQXP stock is up 9.93% today. Newlink Genetics Cor (NLNK): NLNK stock is up 9.79% today. Achillion Pharmaceut (ACHN): ACHN....More>>>
Allergan (NYSE:AGN) stock has been performing very poorly as of late. Trump’s victory earlier this month rallied the whole biotech complex but unfortunately Allergan’s rally was short lived. The stock is now trading at sub $200 levels which means its earnings multiple is now much lower than the industry’s average of 17.6. Many investors have turned bearish on this stock because....More>>>
Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck (MRK) over the intellectual property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. Gabelli’s Jing He stands by her contention that Gilead is “the most undervalued stock” in biotech:
Gilead Sciences CEO John Milligan Victor J. Blue/Bloomberg News
On June 6, 2016,....More>>>
Boston, MA, based Investment company Adage Capital Partners Gp Llc buys Wells Fargo, General Dynamics, Puma Biotechnology, Johnson Controls International PLC, NextEra Energy, Walt Disney Co, The Mosaic Co, PerkinElmer, Goldman Sachs Group, NXP Semiconductors NV, sells Puma Biotechnology, LinkedIn, Sempra Energy, Allergan PLC, Honeywell International during the 3-months ended 2016-12-31, according....More>>>
The Republican win is an unexpected event that will ironically add to an already long list of headwinds Valeant Pharmaceuticals (NYSE:VRX) faces. Markets are now pricing in interest rate risks in the entire biotechnology sector. As interest on debt costs go up, biotech stocks in the early innings of drug development will have less money available for funding their clinical studies. Markets reacted....More>>>
Poor Caterpillar (CAT). Everything had been looking up for the company, and then suddenly it wasn’t. Does that make it a perfect time for an upgrade?
Agence France-Presse/Getty Images
Caterpillar had rebounded with the global economy and as part of the Trump trade, helping to push its shares up 25% over the past 12 months. Its shares, however, have dropped 5.3% during the past....More>>>
Reports suggest that Gilead Sciences (GILD) and Celgene (CELG) have joined the bidding process forMedivation (MDVN), one that already includes (maybe) Amgen (AMGN), and of course Sanofi (SNY), which is trying to throw out Medivation’s board. Of the three biotech giants, Citigroup’s Robyn Karnauskas and team argue that Amgen is best positioned to win the battle. They explain why:
ImmunoGen (NASDAQ:IMGN) is a clinical stage biotech company that is focused on cancer therapeutics. It has developed an antibody-drug conjugate or “ADC” technology which is already being used in an approved and marketed product and is also being developed for use in a few other clinical stage candidates that are part of ImmunoGen’s current pipeline. The lead pipeline candidate....More>>>
Stocks edged higher today despite Donald Trump trashing the health care sector in his press conference today.
The S&P 500 rose 0.3% to 2,275.32 today, while the Dow Jones Industrial Average gained 98.75 points, or 0.5%, to 19,954.28. The Nasdaq Composite advanced 0.2% to5,563.65–and hit its fifth consecutive high–despite the fact that biotech stocks tumbled....More>>>
Related MRK Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim The Stocks That Moved The S&P, Dow And Nasdaq Today The Vetr community has upgraded $MRK to 3.5-Stars. (Vetr) Related ONVO Add 3D Printing To Your Portfolio With These Stocks Organovo Holdings Sees FY 2016....More>>>